Thus, the overall lifetime risk of breast cancer for women carrying a BRCA1/2 mutation is between 50% and 80%, while the lifetime risk for ovarian cancer is 15% to 40% [14]. The gene discussed is BRCA1; the disease is ovarian cancer.